Global Ophthalmic Drugs Contract Manufacturing Market Study, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030" report has been added to ResearchAndMarkets.com's offering. Current estimates indicate that the total economic burden related to vision loss is expected to reach approximately USD 384 billion by 2030, in the US alone Ophthalmic Drugs C

Full Story →